PYXS — Pyxis Oncology, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1782223 ·
Last close
$2.33
Market Cap
$194.34M
52W High
$5.55
52W Low
$1.03
ADV30
1,069,905
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -25,990,000 | -25,346,000 | 54,922,000 | 18,855,000 | 43,482,000 |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 11,038,000 | 8,650,000 | -18,295,000 | -18,106,000 | 91,520,000 | 15,422,000 | 38,112,000 |
| Sep 2025 | 0 | 0 | -23,461,000 | -22,003,000 | 105,604,000 | 8,919,000 | 36,825,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-66,967,000
Investing CF
$59,405,000
Financing CF
$569,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.37
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-466,449,000
Inventory
—
Receivables
$700,000
ST Investments
$35,252,000
EBIT TTM
$-85,866,000
Pretax Income TTM
$-80,349,000
Interest Exp TTM
—
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$11,038,000
EBITDA
$-85,526,000
Free Cash Flow
$-23,186,750
Enterprise Value
$252,575,840
Total Cash
$32,996,000
Total Debt
$17,832,000
Shares Out
83,408,050
Trailing EPS
$-1.40
Book Value
$0.18
ROE
-179.1%
ROA
-63.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,858,000 | -84,420,000 | -79,621,000 | 91,520,000 | 38,112,000 | 53,408,000 | -63,502,000 |
| Dec 2024 | 16,146,000 | -68,496,000 | -77,331,000 | 157,181,000 | 36,430,000 | 120,751,000 | -57,672,000 |
| Dec 2023 | 0 | -82,196,000 | -73,790,000 | 173,726,000 | 48,022,000 | 125,704,000 | -70,709,000 |
| Dec 2022 | 0 | -123,481,000 | -120,717,000 | 211,379,000 | 50,555,000 | 160,824,000 | -89,335,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.13
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $2.33 · call volume: 88 · put volume: 428
Expected Move to 2026-10-16:
±$0.63
(27.04%) —
implied range
$1.70 –
$2.96
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ORMP | ORAMED PHARMACEUTICALS INC. | $194.26M | $4.67 | — |
| ALXO | ALX ONCOLOGY HOLDINGS INC | $192.21M | $1.39 | — |
| ANTX | AN2 Therapeutics, Inc. | $200.76M | $5.32 | — |
| CUE | Cue Biopharma, Inc. | $187.93M | $25.87 | — |
| NKTX | Nkarta, Inc. | $187.66M | $2.62 | — |
News headlines (Yahoo Finance, 1h cache)
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
2026-09-30 05:11 · Yahoo
Pyxis Oncology Announces Proposed Public Offering
2026-09-29 20:24 · Yahoo
Pyxis Oncology shares fall 7% despite updated MICVO trial results
2026-09-09 14:08 · Yahoo
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+
2026-09-09 11:00 · Yahoo
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcin
2026-09-08 20:01 · Yahoo
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
2026-09-08 11:30 · Yahoo
Pyxis Oncology to Participate in Upcoming Investor Conferences
2026-09-01 11:30 · Yahoo
Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
2026-08-13 11:00 · Yahoo
Pyxis Oncology Secures Up to $114 Million Private Placement
2026-06-30 14:30 · Yahoo
Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
2026-05-14 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.